These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19728904)

  • 1. [Prognosis of rectal cancer patients after total mesorectal excision].
    Pan ZZ; Ding PR; Wan DS; Li LR; Wu XJ; Lu ZH; Kong LH; Lin JZ; Zhou ZG
    Ai Zheng; 2009 Sep; 28(9):903-7. PubMed ID: 19728904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
    Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
    Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
    Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
    Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
    Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
    Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
    Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
    Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
    Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
    Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of adenocarcinoma of the rectum.
    Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
    Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases.
    Park YJ; Park KJ; Park JG; Lee KU; Choe KJ; Kim JP
    World J Surg; 1999 Jul; 23(7):721-6. PubMed ID: 10390594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer.
    Miki H; Akiyoshi T; Ogura A; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Noma H; Saiura A; Fukunaga Y; Ueno M
    Dig Surg; 2018; 35(5):389-396. PubMed ID: 28858867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
    Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total mesorectal excision versus conventional radical surgery for rectal cancer: a meta analysis].
    Liang YC; Qing SH; Ding WX; Chen PY; Huang YB; Yu HT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):43-8. PubMed ID: 17253173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma].
    Lin JZ; Pan ZZ; Zeng ZF; Ding PR; Wan DS
    Ai Zheng; 2009 Sep; 28(9):919-22. PubMed ID: 19728907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
    Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
    Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.